AAAAAA
Results:
1-7
|
Results: 7
Authors:
Samsa, GP
Kolotkin, RL
Williams, GR
Nguyen, MH
Mendel, CM
Citation: Gp. Samsa et al., Effect of moderate weight loss on health-related quality of life: An analysis of combined data from 4 randomized trials of sibutramine vs placebo, AM J M CARE, 7(9), 2001, pp. 875-883
Authors:
Dujovne, CA
Zavoral, JH
Rowe, E
Mendel, CM
Citation: Ca. Dujovne et al., Effects of sibutramine on body weight and serum lipids: A double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia, AM HEART J, 142(3), 2001, pp. 489-497
Authors:
Schuh, LM
Schuster, CR
Hopper, JA
Mendel, CM
Citation: Lm. Schuh et al., Abase liability assessment of sibutramine, a novel weight control agent, PSYCHOPHAR, 147(4), 2000, pp. 339-346
Authors:
McMahon, FG
Fujioka, K
Singh, BN
Mendel, CM
Rowe, E
Rolston, K
Johnson, F
Mooradian, AD
Citation: Fg. Mcmahon et al., Efficacy and safety of sibutramine in obese white and African American patients with hypertension - A 1-year, double-blind, placebo-controlled, multicenter trial, ARCH IN MED, 160(14), 2000, pp. 2185-2191
Authors:
Bach, DS
Rissanen, AM
Mendel, CM
Shepherd, G
Weinstein, SP
Kelly, F
Seaton, TB
Patel, B
Pekkarinen, TA
Armstrong, WF
Citation: Ds. Bach et al., Absence of cardiac valve dysfunction in obese patients treated with sibutramine, OBES RES, 7(4), 1999, pp. 363-369
Authors:
Bray, GA
Blackburn, GL
Ferguson, JM
Greenway, FL
Jain, AK
Mendel, CM
Mendels, J
Ryan, DH
Schwartz, SL
Scheinbaum, ML
Seaton, TB
Citation: Ga. Bray et al., Sibutramine produces dose-related weight loss, OBES RES, 7(2), 1999, pp. 189-198
Authors:
Lee, Y
Conroy, JA
Stepanavage, ME
Mendel, CM
Somers, G
McLoughlin, DA
Olah, TV
De Smet, M
Keymeulen, B
Rogers, JD
Citation: Y. Lee et al., Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers, BR J CL PH, 47(4), 1999, pp. 373-378
Risultati:
1-7
|